Provided is a fluorine-containing siloxane acrylate represented by formula (1).

X—Z-PFPE-Z—X   (1)

[PFPE is a divalent perfluoropolyether chain, X is a group represented by formula (2)

##STR00001##

{Y.sup.1 is a divalent organic group, R.sup.2 is a hydrogen atom, a fluorine atom, a methyl group, or a trifluoromethyl group, and G is a monovalent hydrocarbon group or a group represented by formula (3)

O—Si(CH.sub.3).sub.2—Y.sup.1—OR.sup.1   (3)

(R.sup.1 is a monovalent hydrocarbon group, and Y.sup.1 is same as mentioned above. The broken line represents a bond (hereinafter, the same shall apply.)) Q is a hydrogen atom or a group represented by formula (4)

SiR.sup.3.sub.3   (4)

(R.sup.3 is a monovalent hydrocarbon group.) e is an integer of 0-2, f is an integer of 0-2, and g is an integer of 1-3, and e+f+g is 3.} Z is a predetermined divalent organic group.]

Some embodiments relate to a method for depositing a silicon precursor on a substrate. The method comprises obtaining a silicon precursor material comprising at least one siloxane linkage, and obtaining at least one co-reactant precursor material. The silicon precursor material is volatized to obtain a silicon precursor vapor. The at least one co-reactant precursor material is volatized to obtain at least one co-reactant precursor vapor. The silicon precursor vapor and the at least one co-reactant precursor vapor are contacted with the substrate, under chemical vapor deposition conditions, sufficient to form a silicon-containing film on a surface of the substrate. Some embodiments relate to silicon precursor materials for chemical vapor deposition.

The present invention relates to a specific azole silane compound, an oligomer thereof, a mixture comprising said compound and/or said oligomer, as well as a respective storage and working solution. Furthermore, the present invention relates to a synthesis method for said specific azole silane compound, and the use of said working solution as a surface treatment solution.

A purpose of the present invention is to provide a siloxane suitable for preparing a medical material and a method for preparing the compound. The present invention provides a siloxane represented by the formula (1), wherein R.sup.1 is a hydrogen atom or a methyl group, R.sup.2 is a monovalent hydrocarbon group having 1 to 6 carbon atoms, L is a divalent hydrocarbon group which has 2 to 10 carbon atoms and may have one or more ether bonds, and A is a (poly)siloxane group represented by the formula (2) or (3), wherein n is an integer of 1 to 100, a is an integer of 0 to 10, b is an integer of 0 to 10, and c is an integer of 0 to 10, provided that a+b+c is 2 or more, and R is, independently of each other, a monovalent hydrocarbon group having 1 to 10 carbon atoms. The present invention further provides a method for preparing the siloxane, a polymer comprising recurring units derived from the siloxane, and a medical material, particularly an ophthalmic device, comprising the aforesaid polymer.

A compound of Formula (5-1) or Formula (5-3):

##STR00001##

where R.sup.17 and R.sup.21 are each an ethyl group; R.sup.22 and R.sup.23 are each a methyl group; and R.sup.16 and R.sup.20 are each a methoxy group.

Healthcare formulations, including, inventive surfactants, Active ingredient formulated as solids, liquids, or emulsions. The present disclosure provides formulations of healthcare products, such as: prescription drugs, over the counter drugs; minerals, herbal, and/or vitamin supplements; drugs administered in hospitals, clinics, physician's office, and places of palliative care; vaccines, tissue, organ, and cell transplants and/or grafts and/or infusions; and wound care formulations including topical ointments, lotions, cleaners, wipes, bandages, and dressings. The Active may be included in the formulations as a solute, a solvent, a particle, or an oil immiscible component of the formulation. The Active may be included in tablets, capsules, tinctures, liquids, or emulsions. Inventive healthcare formulations include formulations suitable for administration orally, topically, and/or by injection.

A mixture M includes at least one compound A selected from (a1) a compound of the general formula (I): R.sup.1R.sup.2R.sup.3Si—H, and/or (a2) a compound of the general formula (I′): (SiO.sub.4/2).sub.a(R.sup.xSiO.sub.3/2).sub.b(HSiO.sub.3/2).sub.b′(R.sup.x.sub.2SiO.sub.2/2).sub.c(R.sup.xHSiO.sub.2/2).sub.c′(H.sub.2SiO.sub.2/2).sub.c″(R.sup.x.sub.3SiO.sub.1/2).sub.d(HR.sup.x.sub.2SiO.sub.1/2).sub.d′(H.sub.2R.sup.xSiO.sub.1/2).sub.d″(H.sub.3SiO.sub.1/2).sub.d′″, and at least one compound B selected from (b1) a compound of the general formula (II): R.sup.4R.sup.5R.sup.6Si—O—R.sup.7, and/or (b2) a compound of the general formula (II′): R.sup.x.sub.3Si—O[—SiR.sup.x.sub.2—O].sub.m—[Si(OR.sup.7.sub.3)R.sup.x—O].sub.n—SiR.sup.x.sub.3, and at least one compound C selected from the cationic germanium(II) compound of the general formula (III): ([Ge(II)Cp].sup.+).sub.aX.sup.a−.

This organopolysiloxane which has a constituent unit represented by general formula (1) and a group represented by general formula (2), said group being directly bonded to a silicon atom, enables a curable composition containing a polyisocyanate compound to achieve a good balance between fast curing properties and storage stability, and enables the achievement of a cured product that has excellent hardness, heat resistance and wet heat resistance.

##STR00001##

(In formula (1), each of R.sup.1A and R.sup.1B independently represents a hydrogen atom, an alkyl group having from 1 to 10 carbon atoms, or an aryl group having from 6 to 10 carbon atoms; and A.sup.1 represents an unsubstituted or substituted divalent hydrocarbon group having from 1 to 20 carbon atoms and optionally having a hetero atom.)

R.sup.2O—  (2)

(In formula (2), R.sup.2 represents a hydrogen atom, an unsubstituted or substituted alkyl group having from 1 to 10 carbon atoms, or an unsubstituted or substituted aryl group having from 6 to 10 carbon atoms.)

A flame-retarded resin includes at least one resin for which flame retardant capability is desired and at least one triaryl silicon-containing compound (I) as flame retardant in admixture therewith and/or chemically bonded, e.g., grafted, to the resin.

Pre-texturing agents, etchants, and photoresist stripping agents may be formulated to include one or more surfactants, from one or more surfactant classes, such as siloxane derivatives of amino acids that have surface-active properties.